Leptomeningeal metastasis from solid tumours : EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
ESMO open - 8(2023), 5 vom: 20. Okt., Seite 101624 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Le Rhun, E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Central nervous system |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.esmoop.2023.101624 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363558756 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363558756 | ||
| 003 | DE-627 | ||
| 005 | 20231226093613.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.esmoop.2023.101624 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1211.xml |
| 035 | |a (DE-627)NLM363558756 | ||
| 035 | |a (NLM)37863528 | ||
| 035 | |a (PII)S2059-7029(23)00859-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Le Rhun, E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Leptomeningeal metastasis from solid tumours |b EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a central nervous system | |
| 650 | 4 | |a cerebral | |
| 650 | 4 | |a cerebrospinal fluid | |
| 650 | 4 | |a clinical practice guideline | |
| 650 | 4 | |a neurological | |
| 650 | 4 | |a recommendations | |
| 700 | 1 | |a Weller, M |e verfasserin |4 aut | |
| 700 | 1 | |a van den Bent, M |e verfasserin |4 aut | |
| 700 | 1 | |a Brandsma, D |e verfasserin |4 aut | |
| 700 | 1 | |a Furtner, J |e verfasserin |4 aut | |
| 700 | 1 | |a Rudà, R |e verfasserin |4 aut | |
| 700 | 1 | |a Schadendorf, D |e verfasserin |4 aut | |
| 700 | 1 | |a Seoane, J |e verfasserin |4 aut | |
| 700 | 1 | |a Tonn, J-C |e verfasserin |4 aut | |
| 700 | 1 | |a Wesseling, P |e verfasserin |4 aut | |
| 700 | 1 | |a Wick, W |e verfasserin |4 aut | |
| 700 | 1 | |a Minniti, G |e verfasserin |4 aut | |
| 700 | 1 | |a Peters, S |e verfasserin |4 aut | |
| 700 | 1 | |a Curigliano, G |e verfasserin |4 aut | |
| 700 | 1 | |a Preusser, M |e verfasserin |4 aut | |
| 700 | 0 | |a EANO Guidelines Committee and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ESMO open |d 2016 |g 8(2023), 5 vom: 20. Okt., Seite 101624 |w (DE-627)NLM266189539 |x 2059-7029 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2023 |g number:5 |g day:20 |g month:10 |g pages:101624 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.esmoop.2023.101624 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2023 |e 5 |b 20 |c 10 |h 101624 | ||